NFKB1 and neoplasm: Indeed, intratumoral microbiota can affect therapeutic outcomes by influencing both tumour-intrinsic and extrinsic factors, including genetic and epigenetic expression in tumour cells, signalling pathways like Wnt/β-catenin and NF-κB, metabolism of anti-cancer drugs, and immune cell infiltration and function [85].